All‐cause mortality during hospital stay · people with critical limb ischaemia
1 finding from 1 review
Reduction in rest pain: rest pain score · people with critical limb ischaemia
1 finding from 1 review
All‐cause mortality during hospital stay · people with critical limb ischaemia
1 finding from 1 review
Rate of amputation · people with critical limb ischaemia
It is very uncertain whether high cell dose changes amputation rate Assessed during in‐patient stay (Losordo 2012) compared with low cell dose (very low certainty).
1 finding from 1 review
Ulcer healing · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rest‐pain relief · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality during hospital stay · people with critical limb ischaemia
1 finding from 1 review
Rate of amputation · people with critical limb ischaemia
BM‐MNCs showed no clear difference in amputation rate Assessed during in‐patient stay compared with mPBSCs (low certainty).
1 finding from 1 review
Rate of amputation · people with critical limb ischaemia
IM injection showed no clear difference in amputation rate Assessed during in‐patient stay compared with IA injection (low certainty).
1 finding from 1 review
Wound/ulcer healing: number of participants with healing ulcer · people with critical limb ischaemia
IM injection showed no clear difference in wound/ulcer healing: number of participants with healing ulcer compared with IA injection (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
IM injection showed no clear difference in reduction in rest pain: number of participants with reduction in… compared with IA injection (low certainty).
1 finding from 1 review
Ulcer healing · people with critical limb ischaemia
BM‐MNCs showed no clear difference in wound/ulcer healing: number of participants with healing ulcers… compared with mPBSCs (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
BM‐MNCs showed no clear difference in reduction in rest pain: number of participants with any reduction in… compared with mPBSCs (moderate certainty).
1 finding from 1 review
All‐cause mortality during hospital stay · people with critical limb ischaemia
1 finding from 1 review
Rate of amputation · people with critical limb ischaemia
1 finding from 1 review
Wound/ulcer healing: number of participants with healing ulcer · people with critical limb ischaemia
BM‐MNCs probably leads to higher wound/ulcer healing: number of participants with healing ulcers compared with BM‐MSCs (moderate certainty).
1 finding from 1 review
Deep vein thrombosis · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin probably leads to lower deep venous thrombosis compared with no prophylaxis or placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in pulmonary embolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Symptomatic venous thromboembolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin may leads to lower symptomatic venous thromboembolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Mortality due to pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
1 finding from 1 review